by Henrianne DE PONTBRIAND | 11 Mar, 2019 | Bioethics press synthesis | All other themes
By a resolution adopted on 14 February, the European Parliament has condemned operations to “normalise children born with a difference in sexual development”[1]. These practices are also being challenged by “more and more doctors”. In...
by Henrianne DE PONTBRIAND | 11 Mar, 2019 | Bioethics press synthesis | Genome
The Swiss biotechnology company CRISPR Therapeutics has announced that it has used CRISPR to treat a patient with beta-thalassemia. This experiment was sponsored by Vertex Pharmaceuticals of Boston (see Americans finance an initial clinical trial using CRISPR/Cas9 in...
by Henrianne DE PONTBRIAND | 11 Mar, 2019 | Bioethics press synthesis | Genome
Following the “GMO babies affair” (see GMO babies: guinea pigs against their will), China has drawn up new regulations for genetic research. These regulations make provision to classify as “high risk” all “work on genetic...
by Henrianne DE PONTBRIAND | 11 Mar, 2019 | Bioethics press synthesis | Prenatal diagnosis
Ultrasound can detect certain malformations and anomalies in foetal development. In this case, we can look for a genetic cause using karyotyping[1] and chromosomal microarray analysis (CMA)[2]. In about 38% of cases, these analyses determine the cause of the disorder,...
by Henrianne DE PONTBRIAND | 7 Mar, 2019 | Bioethics press synthesis | Abortion - Medical termination of Pregnancy(MTP)
Adopted in 2014, the law argued that “the state should not be required to pay for elective abortions”. On this basis, “medically necessary” abortions were defined as those that could “avoid a threat of serious risk to a woman’s life...